Are There Prenatal Tests For Down Syndrome? | What To Expect

Yes—pregnancy screening and diagnostic tests can estimate or confirm trisomy 21, starting as early as the first trimester.

Hearing the words “Down syndrome test” can make a normal appointment feel heavy. Most people want the same thing: clear choices, plain-language results, and a timeline that doesn’t leave them guessing.

This article breaks down the prenatal testing options linked to Down syndrome (trisomy 21), what each option can and can’t tell you, and how to turn a result into next steps.

What Down Syndrome Testing Is Really Checking

Down syndrome is most often caused by an extra copy of chromosome 21. That’s why you’ll also hear “trisomy 21.” Prenatal testing looks for signals that chromosome 21 is present in an extra amount.

Tests fall into two buckets. Screening estimates chance. Diagnostic testing can confirm the chromosome pattern by testing cells from the placenta or the amniotic fluid.

Prenatal Tests For Down Syndrome With Clear Trade-Offs

People often ask for “the test,” but there isn’t just one. You’re picking between screening vs diagnosis, and you’re picking when you want the information. Timing matters because it affects what else can be checked on ultrasound and how quickly you can move to confirmation.

Screening Tests: Chance, Not Certainty

Screening tests don’t examine fetal chromosomes directly. They use patterns in blood markers, ultrasound measurements, or placental DNA fragments in your blood. A “higher chance” screening result is a signal to offer more evaluation.

ACOG’s patient overview explains the main screening options and the way results are reported. Prenatal genetic screening tests is a useful reference for the standard choices.

First-Trimester Blood Screening Plus Nuchal Translucency

This approach uses a blood test and an ultrasound measurement called nuchal translucency (the fluid space at the back of the baby’s neck). It’s usually done around 11–14 weeks.

The results are combined into a chance estimate, such as “1 in 500” or “1 in 50.” That number is not a diagnosis. It’s a probability estimate based on the markers collected.

Second-Trimester Blood Screening

If first-trimester screening isn’t done, some people are offered a second-trimester blood screen (often called a “quad” screen). It looks at four markers and returns a chance estimate.

It’s often paired with the mid-pregnancy ultrasound because imaging can add useful context about growth and anatomy.

Cell-Free DNA Screening (NIPT)

Cell-free DNA screening (often called NIPT) looks at small fragments of DNA from the placenta that circulate in a pregnant person’s blood. It can be done early, often starting at 10 weeks, and it has strong screening performance for trisomy 21 compared with older blood screens.

NIPT is still screening. Results can be false-positive or false-negative. If it suggests a higher chance of trisomy 21, the next step is usually an ultrasound review and the offer of diagnostic testing.

Ultrasound Findings: Useful Clues

Ultrasound can show findings that raise or lower concern for chromosome differences. Some findings are called “soft markers,” which means they can also show up in pregnancies where chromosomes are typical.

The mid-pregnancy anatomy scan checks structures across the body. It can also reveal findings that lead to a conversation about genetic screening or diagnosis, even if earlier screening was not done.

Timing: When Each Test Usually Fits

Most prenatal testing choices are shaped by weeks of gestation. The same result can feel different at 10 weeks versus 20 weeks because of what else can be seen on ultrasound and which diagnostic procedures still fit your timeline.

If you’re in the UK, the NHS describes the combined test timing and how chance language is used. Screening for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome is a clear walkthrough.

Here’s a quick map of common options and what they’re designed to tell you.

Test	Usual Timing	What It Can Tell You
Nuchal translucency ultrasound	11–14 weeks	Raises or lowers concern for chromosome differences; not diagnostic.
First-trimester blood screening	10–13 weeks	Chance estimate for trisomy 21 based on blood markers; not diagnostic.
Combined first-trimester screening	11–14 weeks	Chance estimate using blood markers plus nuchal translucency.
Cell-free DNA screening (NIPT)	10 weeks and later	Screening estimate for trisomy 21 using placental DNA fragments; not diagnostic.
Second-trimester “quad” screen	15–22 weeks	Chance estimate using four blood markers; not diagnostic.
Chorionic villus sampling (CVS)	10–13 weeks	Diagnostic testing of placental cells to confirm chromosome findings.
Amniocentesis	15–20 weeks	Diagnostic testing of fetal cells from amniotic fluid to confirm chromosome findings.
Anatomy ultrasound	18–22 weeks	Checks fetal structures; may add context for genetic chances.

Screening Results: How To Read The Numbers

Screening results often look like odds: 1 in 1,000, 1 in 200, 1 in 30. That format can feel like a verdict. It isn’t.

A “1 in 200” result means that if 200 pregnancies had that same screening pattern, one might have trisomy 21 and 199 would not. Screening sorts pregnancies into “lower chance” and “higher chance” groups so that next steps can be offered.

Why False Positives Can Happen

Screening uses indirect signals. Blood markers shift for many reasons. Ultrasound markers can be normal variants. Cell-free DNA comes from the placenta, and placental DNA can differ from the fetus in rare cases.

So a higher-chance screen is usually followed by an offer of diagnostic testing if you want confirmation during pregnancy.

Positive Predictive Value Changes By Person

Two people can get the same NIPT report and have different odds that the result reflects the fetus. Age, ultrasound findings, and prior history can change the starting chance. Your clinician can translate the report into a clearer “how likely is it” estimate for your situation.

Diagnostic Tests: Getting A Confirmed Answer In Pregnancy

Diagnostic testing looks directly at fetal or placental cells and can confirm trisomy 21. The two main procedures are chorionic villus sampling (CVS) and amniocentesis.

ACOG summarizes how these tests work and when they’re done. Prenatal genetic diagnostic tests is a solid patient reference.

Chorionic Villus Sampling (CVS)

CVS samples a small amount of placental tissue. It’s usually done in the 10–13 week range, which can feel like a big advantage if you want answers earlier.

Sometimes the lab sees mosaic patterns or results that need extra interpretation. In that case, you may be offered follow-up testing to clarify what’s going on.

Amniocentesis

Amniocentesis removes a small amount of amniotic fluid through a thin needle under ultrasound guidance. The fluid contains fetal cells that can be tested for chromosome conditions, including trisomy 21.

MedlinePlus explains the test and the typical timing. Amniocentesis (amniotic fluid test) notes that it’s often done during weeks 15–20.

What About Procedure Risks?

Many people fixate on one question: “What’s the miscarriage risk?” The best estimate depends on the clinic’s experience, the technique used, and pregnancy details.

Ask your care team what number they quote in their setting, how they define a procedure-related loss, how many they perform each year, and whether continuous ultrasound guidance is used.

Are There Prenatal Tests For Down Syndrome? Choosing What Fits You

There’s no one “right” choice. The right choice is a match between your timeline, how much certainty you want in pregnancy, and your comfort with the trade-offs of a procedure.

When Screening Often Fits Best

• You want a low-risk first step.
• You’d like to sort into lower chance vs higher chance before choosing more testing.
• You want time to think through options before deciding on diagnosis.

When Diagnosis Often Fits Best

• You want a confirmed answer in pregnancy.
• You’ve had a higher-chance screen and want clarity.
• An ultrasound finding raises concern and you want to know the chromosome result.

Questions That Make Appointments More Useful

Appointments move fast. A short list of questions can turn a confusing report into a plan you can live with.

Topic	Questions To Ask	What You Get From Asking
Test type	Is this screening or diagnosis?	Clarity on certainty.
Numbers	What does “1 in X” mean in plain language for me?	A grounded read of the result.
NIPT reports	What is the positive predictive value for my report?	A better sense of what the result likely reflects.
Ultrasound	Do ultrasound findings change the chance estimate?	Context that blends tests and imaging.
Next step	What are my options if this is higher chance?	A clear path from result to action.
Diagnostic choice	If I want confirmation, is CVS or amniocentesis a better fit?	A procedure matched to timing and goals.
Timing	When will results return, and what visit comes next?	Fewer surprises while waiting.
Lab method	Will the lab do karyotype, microarray, or both?	Clarity on what the test can detect.

What Happens After A Higher-Chance Result

A higher-chance result often triggers three steps: confirm what test was done, review ultrasound findings, and decide whether you want diagnostic testing. Some people choose a targeted ultrasound first. Others want diagnosis right away.

If you choose diagnosis, the lab may run different analyses depending on the question being asked. Your clinician can explain which method is being used and what each method can detect.

Takeaway: A Calm Way To Build Your Plan

Yes, there are prenatal tests for Down syndrome, and you can choose the level of certainty that fits you. Screening tests can be a low-risk first step. Diagnostic tests can confirm trisomy 21 in pregnancy.

If you’re unsure where to start, ask two questions: “What does this test tell me?” and “What would we do with each possible result?” That’s often enough to turn a scary topic into a clear plan.